EHV-1, how immunity works
Creating populations of B cells that produce neutralizing EHV-1 mucosal antibodies is key to preventing systemic illness from Equine Herpes Virus-1. Also suggested is the possibility of introducing specific antibodies during outbreaks to introduce immediate immunity. DrO Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 … Read more